Core Viewpoint - The company has adjusted the upper limit of A-share stock issuance to specific targets due to changes in total share capital resulting from various corporate actions, increasing the limit from 21,418,292 shares to 30,032,755 shares [1][4]. Group 1: A-Share Issuance Adjustment - The company’s board approved the adjustment of the upper limit for A-share issuance to not exceed 30,032,755 shares, which is 15% of the total share capital prior to the issuance [1][4]. - The adjustment is a result of the company's annual profit distribution, convertible bond conversions, and stock incentive plans, which have altered the total share capital [2][3]. Group 2: Share Capital Changes - The total share capital increased from 143,062,824 shares to 200,218,370 shares after the profit distribution, which included a cash dividend of 1.00 yuan per share and a capital increase of 0.40 shares per share [3][4]. - The company completed the registration of shares related to the stock incentive plan, contributing to the increase in total share capital [2].

Summary of Key Points Core Viewpoint - The article discusses recent developments in convertible bonds, including shareholder reduction plans, strong redemptions, and new listings on the North Exchange. Group 1: Shareholder Actions - Lino Pharmaceutical's shareholders plan to reduce their holdings by no more than 3.61% of the company's shares [1]. Group 2: Convertible Bonds - Strong redemptions are noted for Haopeng Convertible Bond and Dongcai Convertible Bond, while Zhongqi Convertible Bond will not undergo strong redemption [1]. - Several convertible bonds, including Yirui, Jiayuan, and Jinggong, will not undergo adjustments [1]. - The last trading day for Hexing Convertible Bond is set for August 12, 2025 [1]. Group 3: New Listings - Hongyuan Co., Ltd. will have its new shares available for subscription on August 11, 2023, on the North Exchange [1]. - Youli Intelligent and two South Data Center REITs have been listed [1]. Group 4: Convertible Bond Data - A detailed table of convertible bonds includes information such as current price, redemption price, last trading day, conversion value, remaining scale, and the proportion of convertible bonds to the underlying stock [1][4][6]. - For example, the current price of Hexing Convertible Bond is 111.701, with a redemption price of 110.000 and a last trading day of August 12, 2025 [4].

股票代码：688301 股票简称：奕瑞科技 债券代码：118025 债券简称：奕瑞转债 奕瑞电子科技集团股份有限公司 向不特定对象发行可转换公司债券 第三次临时受托管理事务报告 （2025 年度） 债券受托管理人 二〇二五年六月 重要声明 本报告依据《公司债券发行与交易管理办法》《关于上海奕瑞光电子科技股 份有限公司向不特定对象发行可转换公司债券之债券受托管理协议》（以下简称 "《受托管理协议》"）《上海奕瑞光电子科技股份有限公司向不特定对象发行 可转换公司债券募集说明书》（以下简称"《募集说明书》"）等相关规定，由 本次债券受托管理人中国国际金融股份有限公司（以下简称"中金公司"）编制。 中金公司对本报告中所包含的从上述文件中引述内容和信息未进行独立验证，也 不就该等引述内容和信息的真实性、准确性和完整性做出任何保证或承担任何责 任。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为中金公司所作的承诺 或声明。在任何情况下，投资者依据本报告所进行的任何作为或不作为，中金公 司不承担任何责任。 中国国际金融股份有限公司作为奕瑞电子科技集团 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688301 证券简称：奕瑞科技 公告编号：2025-037 转债代码：118025 转债简称：奕瑞转债 奕瑞电子科技集团股份有限公司 关于实施2024年年度权益分派时可转债转股 价格调整暨转股连续停牌的提示性公告 本次权益分派方案实施后，公司将依据《上海奕瑞光电子科技股份有限公司向不特定对象发行可转换公 司债券募集说明书》中所载的发行条款及相关规定，对"奕瑞转债"当期转股价格进行调整。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 证券停复牌情况：适用 因实施2024年年度权益分派，奕瑞电子科技集团股份有限公司（以下简称"公司"）的相关证券停复牌情 况如下：权益分派公告日前一交易日（2025年6月12日）至权益分派股权登记日期间，公司可转债将停 止转股。 ■ 注：停牌终止日及复牌日可在本公司后续发布的可转债转股价格调整公告中查阅。 一、2024年年度权益分派方案的基本情况 公司2024年年度利润分配方案为：公司2024年年度拟以实施权益分派股权 ...